IFNα-Expressing Amniotic Fluid-Derived Mesenchymal Stem Cells Migrate to and Suppress HeLa Cell-Derived Tumors in a Mouse Model

BACKGROUND: Immunotherapy for cervical cancer with type I interferon (IFN) is limited because of the cytotoxicity that accompanies the high doses that are administered. In this study, we investigated the utilization of amniotic fluid-derived mesenchymal stem cells (AF-MSCs) as a means for delivering...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Liang, Tian, Wang, Dejun, Li, Liru, Cheng, Yan, Guo, Qiuyan, Zhang, Guangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901954/
https://www.ncbi.nlm.nih.gov/pubmed/29760719
http://dx.doi.org/10.1155/2018/1241323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901954/
https://www.ncbi.nlm.nih.gov/pubmed/29760719
http://dx.doi.org/10.1155/2018/1241323

Ejemplares similares